SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSIT is trending due to a published research paper highlighting its APU's potential to match GPU-level AI performance with significantly less energy consumption, sparking discussions about its disruptive potential in the AI infrastructure market. Community members are actively debating whether this news positions GSIT as a long-term player against giants like NVIDIA or if it's a short-lived hype, while also speculating about potential buyouts. The stock's surge has attracted both bullish investors and short-sellers, leading to high trading volume and price volatility.

Richtech Robotics, Inc. engages in the development of robotic technologies. The firm designs, manufactures, and sells robots to restaurants, hotels, senior living centers, casinos, factories, and movie theaters. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company was founded by Zhen Wu Huang and Zhen Qiang Huang on July 19, 2016 and is headquartered in Las Vegas, NV.

Richtech Robotics Inc. - Ordinary Shares - Class B

Richtech Robotics Inc.

Richtech Robotics Inc. is trending as investors anticipate the unveiling of their new AI-powered robot at the upcoming NVIDIA GTC conference, fueling speculation about potential partnerships and advancements in automation. Community discussions revolve around the stock's high short interest and potential for a violent run, with some noting Blackrock's increased share as a positive signal. Others are weighing the company's future prospects against its current market capitalization and revenue.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

GLXY is trending as investors eagerly anticipate upcoming earnings, fueled by a recent strategic investment and growing optimism around its AI data center initiatives. The community is closely watching for updates on the Helios project and potential ERCOT approvals, with many expressing bullish sentiment and speculating about a significant price surge. Discussions also include Galaxy Digital's diversified revenue streams, particularly its digital asset platform, and its potential to outperform competitors in the long term.

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Elevance Health Inc

Elevance Health is trending as investors monitor the potential impact of upcoming earnings and broader sector headwinds. Community members are weighing whether the recent pullback represents a value opportunity or a sign of further struggles, drawing comparisons to competitors like UnitedHealth and Humana. Discussions also involve speculation about potential government intervention and adjustments to ACA subsidies.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group ($UNH) is trending as investors discuss the potential impacts of competitor earnings, a possible resolution to the government shutdown, and related ACA subsidies. Community members are weighing the influence of institutional investors like Warren Buffett, while others debate the significance of ongoing DOJ investigations and their potential effects on the stock's price. Bullish sentiment anticipates a run to $400, while bears foresee a tumble after earnings, creating a tense atmosphere as traders position themselves.

Solid Power, Inc. engages in the manufacture and supply of power batteries. The firm develops all solid state battery cell technology that replaces the liquid or gel polymer electrolyte used in conventional lithium-ion battery cells with a sulfide-based solid electrolyte. It focuses on the development and commercialization of all solid state battery cells and solid electrolyte materials, primarily for the battery-powered electric vehicle market. The company was founded on August 3, 2011 and is headquartered in Louisville, CO.

Solid Power Inc

Solid Power Inc - Ordinary Shares - Class A

Solid Power ($SLDP) is trending amid increasing investor confidence in solid-state battery technology and strategic partnerships with BMW and SK On. Community discussions highlight the potential for safer, higher-energy-density batteries, drawing comparisons to other battery stocks. Many are closely watching for news from upcoming BMW conferences, anticipating a positive catalyst for further gains.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group (REPL) is trending as investors discuss the potential impact of a resubmitted application for its melanoma treatment after previously facing rejection; the FDA acceptance news has sparked both optimism and skepticism. Community members are debating potential short squeezes, upcoming catalysts, and revised price targets, with some cautioning about possible dilution or a pullback. The stock's volatile price action and the broader implications for the biotech sector are also being closely monitored.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices surge, driven by a potential supply squeeze and increased industrial demand; some community members are discussing possible price manipulation and advocating for physical silver investments instead of the ETF. Bullish sentiment is fueled by expectations of continued price increases, while others caution about overbought conditions and potential pullbacks, noting silver's historical volatility relative to gold.

AlphaVest Acquisition Corp. is a blank check company, which engages in effecting a merger, stock exchange, asset acquisition, stock purchase, and reorganization or similar business combination. The company was founded on January 14, 2022 and is headquartered in New York, NY.

AlphaVest Acquisition Corp

AlphaVest Acquisition Corp ($ATMV) is trending due to discussions around a potential short squeeze and high volatility. The community is actively watching for breakouts, particularly above the $16 level, while also noting the stock's low float and potential for rapid price movements. Some traders are also speculating about news related to a merger.

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Neuphoria Therapeutics Inc.

NEUP is trending due to a failed phase 3 trial for its anxiety medication, causing a significant drop in share price and sparking a debate about whether it's an overreaction. The community is weighing the company's cash runway, partnership with Merck for an Alzheimer's drug, and potential for a bounce, with some seeing a buying opportunity while others express concern about the missed endpoints.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


detailsimowner

Simowner Detail